US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 14.870
  • -0.110-0.73%
Close Jul 22 16:00 ET
  • 14.780
  • -0.090-0.61%
Post 16:58 ET
1.30BMarket Cap-5948P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
45.60%66.77M
40.27%206.06M
39.24%59.52M
29.57%51.44M
34.14%49.25M
65.26%45.86M
101.96%146.91M
94.51%42.74M
106.33%39.7M
137.83%36.72M
Selling and administrative expenses
47.32%26.56M
23.25%75.54M
32.57%22.17M
3.46%18.28M
20.57%17.07M
41.44%18.03M
110.20%61.29M
55.04%16.72M
88.07%17.66M
156.27%14.16M
-General and administrative expense
47.32%26.56M
23.25%75.54M
32.57%22.17M
3.46%18.28M
20.57%17.07M
41.44%18.03M
110.20%61.29M
55.04%16.72M
88.07%17.66M
156.27%14.16M
Research and development costs
44.49%40.21M
52.45%130.52M
43.54%37.35M
50.50%33.16M
42.65%32.18M
85.48%27.83M
96.44%85.62M
132.55%26.02M
123.73%22.04M
127.56%22.56M
Operating profit
-45.60%-66.77M
-40.27%-206.06M
-39.24%-59.52M
-29.57%-51.44M
-34.14%-49.25M
-65.26%-45.86M
-101.96%-146.91M
-94.51%-42.74M
-106.33%-39.7M
-137.83%-36.72M
Net non-operating interest income expense
Other net income (expense)
25.79%4.36M
262.67%17.15M
90.05%5.01M
177.73%5.29M
1,694.18%3.39M
346,100.00%3.46M
43,081.82%4.73M
14,533.33%2.63M
27,100.00%1.9M
800.00%189K
Gain on sale of security
25.94%4.37M
262.14%17.19M
88.87%5.02M
179.21%5.29M
1,702.12%3.41M
173,200.00%3.47M
118,550.00%4.75M
--2.66M
--1.9M
--189K
Other non- operating income (expenses)
-150.00%-10K
-122.22%-40K
30.77%-18K
-133.33%-3K
---15K
-300.00%-4K
-20.00%-18K
-285.71%-26K
28.57%9K
----
Income before tax
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
-96.44%-37.8M
-136.09%-36.53M
Income tax
Net income
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
-96.44%-37.8M
-136.09%-36.53M
Net income continuous Operations
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-95.43%-142.18M
-82.83%-40.11M
-96.44%-37.8M
-136.09%-36.53M
Minority interest income
0
0
Net income attributable to the parent company
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
-101.26%-142.18M
-82.83%-40.11M
-96.44%-37.8M
-155.78%-36.53M
Preferred stock dividends
Other preferred stock dividends
0
0
Net income attributable to common stockholders
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
16.68%-142.18M
-82.83%-40.11M
-96.44%-37.8M
68.03%-36.53M
Basic earnings per share
-22.03%-0.72
-9.22%-2.37
-14.29%-0.64
-1.89%-0.54
-1.67%-0.61
-22.92%-0.59
53.03%-2.17
-58.14%-0.56
-60.61%-0.53
88.10%-0.6
Diluted earnings per share
-22.03%-0.72
-9.22%-2.37
-14.29%-0.64
-1.89%-0.54
-1.67%-0.61
-22.92%-0.59
53.03%-2.17
-58.14%-0.56
-60.61%-0.53
88.10%-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 45.60%66.77M40.27%206.06M39.24%59.52M29.57%51.44M34.14%49.25M65.26%45.86M101.96%146.91M94.51%42.74M106.33%39.7M137.83%36.72M
Selling and administrative expenses 47.32%26.56M23.25%75.54M32.57%22.17M3.46%18.28M20.57%17.07M41.44%18.03M110.20%61.29M55.04%16.72M88.07%17.66M156.27%14.16M
-General and administrative expense 47.32%26.56M23.25%75.54M32.57%22.17M3.46%18.28M20.57%17.07M41.44%18.03M110.20%61.29M55.04%16.72M88.07%17.66M156.27%14.16M
Research and development costs 44.49%40.21M52.45%130.52M43.54%37.35M50.50%33.16M42.65%32.18M85.48%27.83M96.44%85.62M132.55%26.02M123.73%22.04M127.56%22.56M
Operating profit -45.60%-66.77M-40.27%-206.06M-39.24%-59.52M-29.57%-51.44M-34.14%-49.25M-65.26%-45.86M-101.96%-146.91M-94.51%-42.74M-106.33%-39.7M-137.83%-36.72M
Net non-operating interest income expense
Other net income (expense) 25.79%4.36M262.67%17.15M90.05%5.01M177.73%5.29M1,694.18%3.39M346,100.00%3.46M43,081.82%4.73M14,533.33%2.63M27,100.00%1.9M800.00%189K
Gain on sale of security 25.94%4.37M262.14%17.19M88.87%5.02M179.21%5.29M1,702.12%3.41M173,200.00%3.47M118,550.00%4.75M--2.66M--1.9M--189K
Other non- operating income (expenses) -150.00%-10K-122.22%-40K30.77%-18K-133.33%-3K---15K-300.00%-4K-20.00%-18K-285.71%-26K28.57%9K----
Income before tax -47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M-96.44%-37.8M-136.09%-36.53M
Income tax
Net income -47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M-96.44%-37.8M-136.09%-36.53M
Net income continuous Operations -47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-95.43%-142.18M-82.83%-40.11M-96.44%-37.8M-136.09%-36.53M
Minority interest income 00
Net income attributable to the parent company -47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M-101.26%-142.18M-82.83%-40.11M-96.44%-37.8M-155.78%-36.53M
Preferred stock dividends
Other preferred stock dividends 00
Net income attributable to common stockholders -47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M16.68%-142.18M-82.83%-40.11M-96.44%-37.8M68.03%-36.53M
Basic earnings per share -22.03%-0.72-9.22%-2.37-14.29%-0.64-1.89%-0.54-1.67%-0.61-22.92%-0.5953.03%-2.17-58.14%-0.56-60.61%-0.5388.10%-0.6
Diluted earnings per share -22.03%-0.72-9.22%-2.37-14.29%-0.64-1.89%-0.54-1.67%-0.61-22.92%-0.5953.03%-2.17-58.14%-0.56-60.61%-0.5388.10%-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg